Canada Markets closed

Tilray (TLRY) in Focus: Stock Moves 9% Higher

Zacks Equity Research

Tilray, Inc. TLRY was a big mover last session, as the company saw its shares rise 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company as the stock is now down 13.7% in the past one-month time frame.

The company has seen six negative estimate revisions in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few months, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Tilray currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.  

Tilray, Inc. Price

Tilray, Inc. Price

Tilray, Inc. price | Tilray, Inc. Quote

A better-ranked stock in the Medical – Drugs industry is Actinium Pharmaceuticals, Inc. ATNM, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is TLRY going up? Or down? Predict to see what others think: Up or Down

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”

Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.6% per year. So be sure to give these hand-picked 7 your immediate attention.

See 7 handpicked stocks now >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Actinium Pharmaceuticals, Inc. (ATNM) : Free Stock Analysis Report
 
Tilray, Inc. (TLRY) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research